Insider Cluster (2 insiders) ·Filed May 22, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $180K total
Actionable Insight • Neutral

The insider sales are immaterial in size and involve only directors, not C-suite. No bearish signal. Monitor for any C-suite selling or larger volume (>0.5% of market cap) in coming weeks, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ABEO ▲ +11.66% at T+60d
NEUTRAL call ✓ call won +11.66% · α vs SPY +8.93% · entry $5.49 → $6.13
Entry anchored
May 22, 2026
via day open
T+1d
+3.64%
call +3.64% · α +3.63%
$5.69
settled 4mo ago
T+5d
+3.64%
call +3.64% · α +2.43%
$5.69
settled 4mo ago
T+20d
+3.92%
call +3.92% · α +5.86%
$5.71
settled 3mo ago
T+60d
+11.66%
call +11.66% · α +8.93%
$6.13
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two directors at Abeona Therapeutics sold a total of $180K in open-market transactions within a week of the company's Q1 2026 earnings report. The sales are small relative to the $315M market cap (0.06%) and are not clustered among C-suite executives, making them routine portfolio adjustments rather than informed selling.

Key Financial Metrics

Direction
selling
Total Value
$180.0K
Insiders
2

Key Facts

  • Director Mark Alvino sold 6,500 shares at $5.46 for $35K on May 22, 2026
  • Director Eric Crombez sold 26,100 shares at $5.53 for $145K on May 15, 2026
  • Total insider sales of $180K represent 0.06% of $315M market cap
  • Both sellers are directors, not C-suite executives
  • Sales occurred 2-9 days after Q1 2026 earnings release (net product revenue $8.7M, net loss -$17.1M)

Financial Impact

Insider sales of $180K, or 0.06% of market cap — trivial

insider ownership

Risk Factors

  • No material risk from this cluster — sales are routine and small

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABEO-1779485088592
19 reports for ABEO
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +3.70%Aug 14, 2026
Filters
Rows
Reports for ABEO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$5.47 $5.57▲ +1.83%▲ +1.01%$5.03 (−8.14%)
Aug 14, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$5.94 $6.06▲ +2.02%▲ +3.21%$5.03 (−15.40%)
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Aug 13, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.98 $7.02▲ +0.57%▲ +1.13%$5.03 (−28.01%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$5.65 $5.72▲ +1.24%▲ +3.47%$5.03 (−11.06%)
Jun 15, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$5.65 $5.72▼ −1.24%▼ −3.47%$5.03 (+11.06%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.77▲ +4.34%▲ +3.67%$5.03 (−9.13%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.65▲ +2.17%▲ +1.74%$5.03 (−9.13%)
Jun 10, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.36 $5.65▼ −5.41%▼ −1.98%$5.03 (+6.25%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 22, 2026